Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
Journal for Immunotherapy of Cancer
|
December 21, 2017
A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancer
Rachel E Sanborn, Helen J Ross, Sandra Aung, et al.
Journal for Immunotherapy of Cancer
|
July 29, 2018
A multi-center phase II study of high dose interleukin-2 sequenced with vemurafenib in patients with BRAF-V600 mutation positive metastatic melanoma
Joseph I Clark, Jatinder Singh, Marc S Ernstoff, et al.
Cancer Discovery
|
April 17, 2019
A First-in-Human Study and Biomarker Analysis of NKTR-214, a Novel IL2Rβγ-Biased Cytokine, in Patients with Advanced or Metastatic Solid Tumors
Salah-Eddine Bentebibel, Michael E Hurwitz, Chantale Bernatchez, et al.
Journal for Immunotherapy of Cancer
|
September 24, 2016
A retrospective analysis of High-Dose Interleukin-2 (HD IL-2) following Ipilimumab in metastatic melanoma
Elizabeth I Buchbinder, Anasuya Gunturi, Jessica Perritt, et al.
Cancer Immunology, Immunotherapy : CII
|
October 8, 2016
Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinoma
Ajjai Alva, Gregory A Daniels, Michael K K Wong, et al.
Cancer Discovery
|
May 23, 2020
Bempegaldesleukin (NKTR-214) plus Nivolumab in Patients with Advanced Solid Tumors: Phase I Dose-Escalation Study of Safety, Efficacy, and Immune Activation (PIVOT-02)
Adi Diab, Nizar M Tannir, Salah-Eddine Bentebibel, et al.
Clinical Genitourinary Cancer
|
December 6, 2016
Impact of Sequencing Targeted Therapies With High-dose Interleukin-2 Immunotherapy: An Analysis of Outcome and Survival of Patients With Metastatic Renal Cell Carcinoma From an On-going Observational IL-2 Clinical Trial: PROCLAIM<sup>SM</sup>
Joseph I Clark, Michael K K Wong, Howard L Kaufman, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
Journal for Immunotherapy of Cancer
|
December 21, 2017
A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancer
Rachel E Sanborn, Helen J Ross, Sandra Aung, et al.
Journal for Immunotherapy of Cancer
|
July 29, 2018
A multi-center phase II study of high dose interleukin-2 sequenced with vemurafenib in patients with BRAF-V600 mutation positive metastatic melanoma
Joseph I Clark, Jatinder Singh, Marc S Ernstoff, et al.
Cancer Discovery
|
April 17, 2019
A First-in-Human Study and Biomarker Analysis of NKTR-214, a Novel IL2Rβγ-Biased Cytokine, in Patients with Advanced or Metastatic Solid Tumors
Salah-Eddine Bentebibel, Michael E Hurwitz, Chantale Bernatchez, et al.
Journal for Immunotherapy of Cancer
|
September 24, 2016
A retrospective analysis of High-Dose Interleukin-2 (HD IL-2) following Ipilimumab in metastatic melanoma
Elizabeth I Buchbinder, Anasuya Gunturi, Jessica Perritt, et al.
Cancer Immunology, Immunotherapy : CII
|
October 8, 2016
Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinoma
Ajjai Alva, Gregory A Daniels, Michael K K Wong, et al.
Cancer Discovery
|
May 23, 2020
Bempegaldesleukin (NKTR-214) plus Nivolumab in Patients with Advanced Solid Tumors: Phase I Dose-Escalation Study of Safety, Efficacy, and Immune Activation (PIVOT-02)
Adi Diab, Nizar M Tannir, Salah-Eddine Bentebibel, et al.
Clinical Genitourinary Cancer
|
December 6, 2016
Impact of Sequencing Targeted Therapies With High-dose Interleukin-2 Immunotherapy: An Analysis of Outcome and Survival of Patients With Metastatic Renal Cell Carcinoma From an On-going Observational IL-2 Clinical Trial: PROCLAIM<sup>SM</sup>
Joseph I Clark, Michael K K Wong, Howard L Kaufman, et al.
Page
of 2